Literature DB >> 20929344

Short communication: quantitative proteomic plasma profiling reveals activation of host defense to oxidative stress in chronic SIV and methamphetamine comorbidity.

Gurudutt Pendyala1, Sunia A Trauger, Gary Siuzdak, Howard S Fox.   

Abstract

The double epidemic of substance abuse and HIV infection is a multifaceted problem To investigate mechanistic clues to the effects of substance abuse on infected individuals we preformed quantitative proteomic profiling of plasma in a methamphetamine treated nonhuman primate model for AIDS. A nontargeted quantitative approach identified extracellular superoxide dismutase to be significantly upregulated by SIV and methamphetamine treatment, and targeted studies revealed an increase in expression in the antioxidant glutathione S-transferase, thus pointing to a compensatory response to increased oxidative stress in methamphetamine-treated animals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20929344      PMCID: PMC3045074          DOI: 10.1089/aid.2010.0090

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  26 in total

1.  Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation.

Authors:  S Z Imam; S F Ali
Journal:  Brain Res       Date:  2000-02-07       Impact factor: 3.252

2.  Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice.

Authors:  J L Cadet; S Ali; C Epstein
Journal:  Ann N Y Acad Sci       Date:  1994-11-17       Impact factor: 5.691

3.  Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment.

Authors:  M R Gluck; L Y Moy; E Jayatilleke; K A Hogan; L Manzino; P K Sonsalla
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

4.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

5.  Methamphetamine selectively alters brain glutathione.

Authors:  C Harold; T Wallace; R Friedman; G Gudelsky; B Yamamoto
Journal:  Eur J Pharmacol       Date:  2000-07-14       Impact factor: 4.432

6.  Proteolytic activities of two types of mannose-binding lectin-associated serine protease.

Authors:  M Matsushita; S Thiel; J C Jensenius; I Terai; T Fujita
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

7.  Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities.

Authors:  Lisa J Madden; Claudia T Flynn; Michelle A Zandonatti; Meredith May; Loren H Parsons; Simon N Katner; Steven J Henriksen; Howard S Fox
Journal:  Neuropsychopharmacology       Date:  2005-02       Impact factor: 7.853

8.  Methamphetamine-induced neuronal damage: a possible role for free radicals.

Authors:  M J De Vito; G C Wagner
Journal:  Neuropharmacology       Date:  1989-10       Impact factor: 5.250

9.  Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.

Authors:  Goro Fukami; Kenji Hashimoto; Kaori Koike; Naoe Okamura; Eiji Shimizu; Masaomi Iyo
Journal:  Brain Res       Date:  2004-07-30       Impact factor: 3.252

10.  Structural abnormalities in the brains of human subjects who use methamphetamine.

Authors:  Paul M Thompson; Kiralee M Hayashi; Sara L Simon; Jennifer A Geaga; Michael S Hong; Yihong Sui; Jessica Y Lee; Arthur W Toga; Walter Ling; Edythe D London
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

View more
  6 in total

1.  Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.

Authors:  Xiaosha Pang; Jun Panee; Xiangqian Liu; Marla J Berry; Sulie L Chang; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-02       Impact factor: 4.147

Review 2.  Methamphetamine toxicity and its implications during HIV-1 infection.

Authors:  Peter S Silverstein; Ankit Shah; Raeesa Gupte; Xun Liu; Robert W Piepho; Santosh Kumar; Anil Kumar
Journal:  J Neurovirol       Date:  2011-07-23       Impact factor: 2.643

3.  Enhanced methamphetamine metabolism in rhesus macaque as compared with human: an analysis using a novel method of liquid chromatography with tandem mass spectrometry, kinetic study, and substrate docking.

Authors:  Ravinder Earla; Santosh Kumar; Lei Wang; Steven Bosinger; Junhao Li; Ankit Shah; Mohitkumar Gangwani; Anantha Nookala; Xun Liu; Lu Cao; Austin Jackson; Peter S Silverstein; Howard S Fox; Weihua Li; Anil Kumar
Journal:  Drug Metab Dispos       Date:  2014-10-09       Impact factor: 3.922

4.  Methamphetamine and inflammatory cytokines increase neuronal Na+/K+-ATPase isoform 3: relevance for HIV associated neurocognitive disorders.

Authors:  Gurudutt Pendyala; James L Buescher; Howard S Fox
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

5.  Immune System and Methamphetamine: Molecular Basis of a Relationship.

Authors:  Katarzyna Macur; Pawel Ciborowski
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

6.  Methamphetamine reduces human influenza A virus replication.

Authors:  Yun-Hsiang Chen; Kuang-Lun Wu; Chia-Hsiang Chen
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.